Related Experiment Video
Updated: May 14, 2026

10:21
Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
Published on: February 21, 2018
CSF1R mutations link POLD and HDLS as a single disease entity
Alexandra M Nicholson1, Matt C Baker, Nicole A Finch
1Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
Neurology
|February 15, 2013
Summary
Pigmented orthochromatic leukodystrophy (POLD) and hereditary diffuse leukoencephalopathy with axonal spheroids (HDLS) are the same disease. CSF1R gene mutations cause both POLD and HDLS, linking these rare neurodegenerative disorders.
Area of Science:
- Neurogenetics
- Molecular Neurology
- Rare Diseases
Background:
- Pigmented orthochromatic leukodystrophy (POLD) and hereditary diffuse leukoencephalopathy with axonal spheroids (HDLS) are rare neurodegenerative disorders with overlapping clinical and pathological features.
- Previously, mutations in the colony-stimulating factor 1 receptor (CSF1R) gene were identified as a cause of HDLS.
- The genetic basis and mechanistic link between POLD and HDLS remained unestablished.
Observation:
- CSF1R gene sequencing was performed on two pathologically confirmed POLD families.
- Brain samples from affected individuals were re-evaluated for HDLS features.
- In vitro functional characterization of wild-type and mutant CSF1R was conducted.
Findings:
- CSF1R mutations were identified in both POLD families studied.
- Immunohistochemical analysis of one family revealed characteristic HDLS findings.
- Functional studies demonstrated that identified CSF1R mutations impair receptor autophosphorylation, similar to previously observed HDLS mutations.
Implications:
- This study provides the first genetic and mechanistic evidence that POLD and HDLS are a single clinicopathologic entity.
- The findings suggest that CSF1R-related leukoencephalopathies represent a spectrum of disease.
- This discovery may impact diagnostic approaches and therapeutic strategies for these rare neurodegenerative disorders.
Related Concept Videos
Regulation of Hematopoietic Stem Cells
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Cystic Fibrosis: Pathogenesis
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Genetic Lingo
Overview

